Buffalo-formed company Athenex gets FDA approval for pre-cancerous skin lesions drug
Buffalo-formed biopharmaceutical company Athenex just got FDA approval for a topical ointment to treat pre-cancerous skin lesions.
and last updated 2020-12-16 11:15:41-05
BUFFALO, N.Y. (WKBW) â Thirty million American suffer from a condition called Actinic Keratosis, a pre-cancerous skin lesion. It s the second most common diagnosis made by dermatologists.
If left untreated, ten to 15 percent of these lesions will develop into skin cancers. Actinic Keratosis afflicts primarily fair-skinned people that have a lot of sun exposure. So what happens is you get a red scaly and crusty lesion, said Dr. Daniel Lang, Senior Director of Corporate Development at Athenex.